Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Poll: Only 26 Percent of Democrats Want Biden To Run in 2024

Plus: Psilocybin microdosing improves mood, vaping regulations backfire, and more...

Reason

Inhale Success: Blakk Tatted Becomes Overnight Millionaire With Hookah Brand

NEW ORLEANS — Blakk Tatted loves the idea of being an overnight success.

Zenger

Will Americans have the right COVID-19 vaccine this fall? Maybe

In a few short months, the weather will turn crisp, the holiday season will draw near, and the coronavirus may embark on its third consecutive winter of death and devastation.

Los Angeles Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Boeing, PriceSmart And 80 Biggest Movers From Yesterday

Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share.

Benzinga

Why BA.5 is not a super-virus, and how the vaccines are still the best option against COVID

The BA.5 “subvariant” of the coronavirus has rapidly become dominant in the United States, and rising COVID-19 case numbers are dashing hopes for a summer break from the pandemic.

The Philadelphia Inquirer

The U.S. Government Had What It Needed To Prevent the Spread of Monkeypox. It Happened Anyway.

Foot-dragging and red tape by the CDC and the FDA have fueled an avoidable outbreak.

Reason

Incyte (INCY) Outperforms Industry YTD: What Lies Ahead?

Image sourced from Shutterstock

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session

Gainers

Benzinga

The scoop on microwaves: myth versus fact about this kitchen staple

Contrary to the belief that microwaves cook from the inside out, they actually heat the outer layers, which transfer heat to the inner portions.

Chicago Sun-Times

Pig organ transplants inch closer with testing in the dead

Researchers at New York University transplanted pig hearts into two brain-dead people over the last month, the latest in a string of developments in the long quest to one day save human lives with animal organs

The Independent UK

States Must Allow Abortions When Woman's Health or Life Is Threatened, Says HHS

Plus: When "anti-wokeness" becomes an obsession, why immigrants are upwardly mobile, and more...

Reason

Akanda To Supply Tetra Bio-Pharma With Cannabis For FDA Trials Of Cancer-Pain Drug

Akanda Corp.

Benzinga

The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Is Biotech Ready for Another Bull Run? 3 Stocks to Get in Ahead of the Crowd

The biotech industry flourished during the height of the COVID-19 pandemic and reported record revenues and earnings last year. Despite the market slowdown, the sector is poised for another bull run, given the continued global fight against COVID-19 and the increasing demand with an aging population. Popular biotech stocks Pfizer…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Alibaba, Zoom Video And 76 Biggest Movers From Yesterday

Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media.

Reason

The FDA Will Consider Whether To Approve a Birth Control Pill for Over-the-Counter Use

If approved, the drug could increase access to effective birth control.

The Guardian - US

FDA could approve over-the-counter purchase of first birth control pill

The agency is considering the application by HRA Pharma to make Opill available without a prescription

Benzinga

Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session

Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study.

Get all your
news in one place.

100’s of premium titles.
One news app.

WEKU

When it comes to darker skin, pulse oximeters fall short

These devices measure blood oxygen levels and can help identify when patients are dangerously ill. But research shows they can deliver misleading results for people with darker skin.

Tribune News Service

Widely used hospital gowns show signs of exposing workers to infection

Disposable gowns designed to deflect the splatter of bodily fluids, used in thousands of U.S. hospitals, have underperformed in recent and ongoing laboratory tests and may fall short of safety standards, leaving health care workers with a greater risk of infection than advertised.

Axios

FDA to consider application for first over-the-counter birth control pill

"This historic application marks a groundbreaking moment in contraceptive access and reproductive equity."

The Independent UK

Over-the-counter birth control? Drugmaker seeks FDA approval

A drug company is seeking U.S. approval for the first birth control pill that women could buy without a prescription

Tribune News Service

Ask the Pediatrician: What should parents know about COVID-19 vaccine for children under 5?

Q: I have heard that there’s an approved COVID-19 vaccine for children under 5. What do I need to know about it?

The Guardian - US

Hopes US baby formula shortage could ease as key Abbott plant restarts

Factory in Sturgis, Michigan shut down in May after storms that produced torrential flooding

The Independent UK

Production resumes at troubled Abbott baby formula factory

Abbot Nutrition says baby formula production has resumed at the Michigan plant whose February shutdown over contamination contributed to a national shortage

1 … 174 175 176 177

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

BristolMyers Squibb Company

95 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.